516
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Carcinoma ex pleomorphic adenoma of the parotid gland: a multi-institutional retrospective analysis in the Northern Japan Head and Neck Cancer Society

, , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 1154-1158 | Received 14 Mar 2016, Accepted 02 May 2016, Published online: 13 Jun 2016

References

  • Gnepp DR. Malignant mixed tumours of the salivary glands: a review. Pathol Annu 1993;28:279–328.
  • Nouraei SA, Hope KL, Kelly CG, McLean NR, Soames JV. Carcinoma ex benign pleomorphic adenoma of the parotid gland. Plast Reconstr Surg 2005;116:1206–13.
  • Klijanienko J, El-Naggar AK, Servois V, Rodriguez J, Validire P, Vielh P. Mucoepidermoid carcinoma ex pleomorphic adenoma: nonspecific preoperative cytologic findings in six cases. Cancer 1998;84:231–4.
  • Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 2001;32:596–604.
  • Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001;23:705–12.
  • Altemani A, Martins MT, Freitas L, Soares F, Araujo NS, Araujo VC. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 2005;46:635–41.
  • Malata CM, Camilleri IG, McLean NR, Piggot TA, Kelly CG, Chippindale AJ, et al. Malignant tumours of the parotid gland: a 12 year review. Br J Plast Surg 1997;50:600–8.
  • Byrne MN, Spector JG. Parotid masses: evaluation, analysis, and current management. Laryngoscope 1988;98:99–105.
  • Lűers JC, Wittekindt C, Streppel M, Guntinas-Lichius O. Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy. Acta Oncol 2009;48:132–6.
  • Antony J, Gopalan V, Smith RA, Lam AK. Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol 2012;6:1–9.
  • Domenick NA, Johnson JT. Parotid tumor size predicts proximity to the facial nerve. Laryngoscope 2011;121:2366–70.
  • Reddy PG, Arden RL, Mathog RH. Facial nerve rehabilitation after radical parotidectomy. Laryngoscope 1999;109:894–9.
  • House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146–7.
  • Stodulski D, Rzepko R, Kowalska B. Carcinoma ex pleomorphic adenoma of major salivary glands–a clinicopathologic review. Otolaryngol Pol 2007;61:687–93.
  • LiVolsi VA, Perzin KH. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer 1977;39:2209–30.
  • Spiro RH. The management of salivary neoplasms: an overview. Auris Nasus Larynx 1985;12:S122–S7.
  • Zbären P, Zbären S, Caversaccio MD, Stauffer E. Carcinoma ex pleomorphic adenoma: diagnostic difficulty and outcome. Otolaryngol Head Neck Surg 2008;138:601–5.
  • Bhattacharyya N, Fried MP. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol 2005;26:39–44.
  • Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World health organisation classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.
  • Kadowaki S, Yatabe Y, Hirakawa H, Komori A, Kondoh C, Hasegawa Y, et al. Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma. Case Rep Oncol 2013;6:450–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.